The neurobiology of depression-revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1615, 2013, Pages

  Albert, Paul R ^a   Benkelfat, Chawki ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Antidepressant; Anxiety; Depression; Epigenetics; Genetics; Serotonin

Indexed keywords

AGGRESSION; BIOCHEMISTRY; DISEASE TREATMENT; ETIOLOGY; FUNCTIONAL ROLE; GENE EXPRESSION; GENETICS; HORMONE; MEDICINE; MENTAL HEALTH; NERVOUS SYSTEM DISORDER; NEUROLOGY;

ANTIDEPRESSANT AGENT; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ANIMAL; DEPRESSION; DRUG EFFECT; EDITORIAL; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; NEUROIMAGING; PATHOPHYSIOLOGY; RAPHE NUCLEUS;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUROIMAGING; RAPHE NUCLEI; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84874509066     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0535     Document Type: Article

References (22)

1. Beaudet A, Descarries L. 1976 Quantitative data on serotonin nerve terminals in adult rat neocortex. Brain Res. 111, 301-309. (doi:10.1016/0006-8993(76)90775-7)
2. Descarries L, Beaudet A, Watkins KC. 1975 Serotonin nerve terminals in adult rat neocortex. Brain Res. 100, 563-588. (doi:10.1016/0006-8993(75)90158-4)
3. Descarries L, Riad M. 2012 Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT. Phil. Trans. R. Soc. B 367, 2416-2425. (doi:10.1098/rstb. 2011.0361)
4. Aznavour N, Benkelfat C, Gravel P, Aliaga A, Rosa-Neto P, Bedell B, Zimmer L, Descarries L. 2009 MicroPET imaging of 5-HT1A receptors in rat brain: a test-retest [18F]MPPF study. Eur. J. Nucl. Med. Mol. Imaging 36, 53-62. (doi:10.1007/s00259-008-0891-1)
5. Riad M, Zimmer L, Rbah L, Watkins KC, Hamon M, Descarries L. 2004 Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J. Neurosci. 24, 5420-5426. (doi:10.1523/JNEUROSCI.0950-04.2004)
6. Sullivan PF, Neale MC, Kendler KS. 2000 Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiat. 157, 1552-1562. (doi:10.1176/appi.ajp.157.10.1552)
7. Talati A, Weissman MM, Hamilton SP. 2013 Using the high-risk family design to identify biomarkers for major depression. Phil. Trans. R. Soc. B 368, 20120129. (doi:10.1098/rstb.2012.0129)
8. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ. 2009 Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342-348. (doi:10.1038/nn.2270)
9. Booij L, Wang D, Lévesque ML, Tremblay RE, Szyf M. 2013 Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression. Phil. Trans. R. Soc. B 368, 20120251. (doi:10.1098/rstb.2012.0251)
10. Mann JJ. 2013 The serotonergic system in mood disorders and suicidal behavior. Phil. Trans. R. Soc. B 368, 20120537. (doi:10.1098/rstb.2012.0537)
11. Anokhin AP, Golosheykin S, Grant JD, Heath AC. 2011 Heritability of delay discounting in adolescence: a longitudinal twin study. Behav. Genet. 41, 175-183. (doi:10.1007/s10519-010-9384-7)
12. Bevilacqua L, Goldman D. 2013 Genetics of impulsive behaviour. Phil. Trans. R. Soc. B 368, 20120380. (doi:10.1098/rstb.2012.0380)
13. Murphy D, Moya PR, Fox MA, Rubenstein LM, Wendland JR, Timpano KR. 2013 Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Phil. Trans. R. Soc. B 368, 20120435. (doi:10.1098/rstb.2012.0435)
14. Rajkowska G. 2003 Depression: what we can learn from postmortem studies. Neuroscientist 9, 273-284. (doi:10.1177/1073858403252773)
15. Fisher PM, Hariri AR. 2013 Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans. Phil. Trans. R. Soc. B 368, 20120192. (doi:10.1098/rstb.2012.0192)
16. Hesselgrave N, Parsey RV. 2013 Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression. Phil. Trans. R. Soc. B 368, 20120004. (doi:10.1098/rstb.2012.0004)
17. Fakra E et al. 2009 Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch. Gen. Psychiat. 66, 33-40. (doi:10.1001/archpsyc.66.1.33)
18. Albert PR. 2012 Transcriptional regulation of the 5-HT1A receptor: implications for mental illness. Phil. Trans. R. Soc. B 367, 2402-2415. (doi:10.1098/rstb.2011.0376)
19. Trivedi MH et al. 2006 Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiat. 163, 28-40. (doi:10.1176/appi.ajp.163.1.28)
20. Blier P, El Mansari M. 2013 Serotonin and beyond: therapeutics for major depression. Phil. Trans. R. Soc. B 368, 20120536. (doi:10.1098/rstb.2012.0536)
21. Young SN. 2013 The effect of raising and lowering tryptophan levels on human mood and social behaviour. Phil. Trans. R. Soc. B 368, 20110375. (doi:10.1098/rstb.2011.0375)
22. Harmer CJ, Cowen PJ. 2013 'It's the way that you look at it'-a cognitive neuropsychological account of SSRI action in depression. Phil. Trans. R. Soc. B 368, 20120407. (doi:10.1098/rstb.2012.0407)